Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Inferior survival, higher tumo...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Inferior survival, higher tumor recurrence and progression rates in primary non-muscle-invasive bladdercancer with impaired egfr

Inferior survival, higher tumor recurrence and progression rates in primary non-muscle-invasive bladdercancer with impaired egfr

Bibliographic Details
Main Authors: Chia-En Li, Hui-Ying Liu, Chih-Hsiung Kang, Ye-In Chang, Hsiu-Pei Tang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-06-01
Series:Urological Science
Online Access:http://www.sciencedirect.com/science/article/pii/S1879522615003279
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S1879522615003279

Similar Items

  • Higher NAFLD fibrosis score is associated with impaired eGFR
    by: Meng-Hsuan Hsieh, et al.
    Published: (2020-01-01)
  • Assessment of recurrence and progression risk in patients with non-muscle invasive bladder cancer
    by: A. I. Rolevich, et al.
    Published: (2016-12-01)
  • The association of tumor location with recurrence free survival in non-muscle invasive bladder cancer
    by: I. Jansen, et al.
    Published: (2020-07-01)
  • The Advanced Age is Effective on Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
    by: Goksel Bayar, et al.
    Published: (2020-10-01)
  • Larger tumors are associated with inferior progression‐free survival of first‐line EGFR‐tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non‐small cell lung cancer
    by: Yingying Pan, et al.
    Published: (2019-04-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...
Cannot write session to /tmp/vufind_sessions/sess_92lr4rt67ncdo2altb4b6obtsh